Updates from The Motley Fool

Latest updates on Alnylam Pharmaceuticals from Fool.com.


Stock Performance

ALNY vs. S&P 500 | 2 Year Performance
ALNY 1-Day Stock Chart
ALNY 5-Day Stock Chart
ALNY 1-Month Stock Chart
ALNY 3-Month Stock Chart
ALNY 6-Month Stock Chart
ALNY 1-Year Stock Chart
ALNY 2-Year Stock Chart
ALNY 5-Year Stock Chart
View Interactive ALNY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alnylam Pharmaceuticals.
Current Price: $60.81
Prev Close: $68.79
Open: $66.80
Bid: $60.00
Ask: $64.80
Day's Range: $60.07 - $66.99
52wk Range: $51.51 - $140.00
Volume: 1,812,918
Avg Vol 796,497
Market Cap: $5.15B
P/E (ttm): -19.94
EPS (ttm): -$3.45
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alnylam Pharmaceuticals.
CAPS Rating 4 out of 5
 
380 Outperform
39 Underperform
CAPS All Stars
 
80 Outperform
15 Underperform

How do you think Alnylam Pharmaceuticals will perform against the market?



You pick for Alnylam Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John M. Maraganore, CEO

81% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alnylam Pharmaceuticals.

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers